MF6
MF6StockSTU
€0.00 ▲ +0.00%
26 mai 2026
M
MF6
€0.00 ▲ +0.00%
26 mai 2026
MF6StockSTU

01 / À propos

MagForce AG develops advanced nanomedicine for cancer therapies. It offers NanoTherm therapy system, a combination of medical devices for the treatment of solid brain tumors; NanoPlan, a software that stimulates the temperature distribution in the treatment area; NanoTherm, a magnetic ferrofluid; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.

Arberion
Loading market data